June 29, 2022

Numinus files a patent covering the application of the rapid production process for psilocybin

Numinus Wellness (CVE: NUMI) CEO Payton Nyquvest joined Steve Darling of Proactive to bring news that the company has filed for patent protection for its sustainable, repeatable and easily scalable process for rapidly generating therapeutic products. from species of psychoactive mushrooms containing psilocybin, other psychoactive compounds.

Nyquvest told Proactive that the company tested the production process to quickly generate a Psilocybe species extract as “proof of concept.” The results revealed a highly efficient and scalable process that can be applied to other psychoactive mushroom species.

Add related topics to MyProactive

Create your account: subscribe and get ahead of news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that nothing posted on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction or investment strategy is…

In exchange for the publishing services rendered by the Company on behalf of Numinus Wellness Inc. named herein, including the Company’s promotion of Numinus Wellness Inc. in any Site Content, the Company…

FOR OUR FULL DISCLAIMER, CLICK HERE